September 2018 PMID 29530796

Testosterone replacement therapy: For whom, when and how?

Christos P Tsametis, Andrea M Isidori

Mentions

9
Peak: 4 in Jul 2020
across 3 sources since Jan 2016

Extended reach

5,296
potential audience

Total likes

55

Video views

3,410

Mentions per month

Jan 2016 – Oct 2020

Where it's discussed

  • X / Twitter4 posts
  • YouTube3 videos
  • Facebook2 posts

AI synopsis

What people are saying

The discussions highlight symptoms such as low libido, obesity, depression, and erectile dysfunction in relation to low testosterone levels, using clinical thresholds and references to scientific articles. The tone is informational and analytical, reflecting a focus on understanding the health implications rather than actively debating or challenging the publication's conclusions.

AgreementNeither agree nor disagree

Discussions focus on physiological aspects of testosterone deficiency and related symptoms but do not express clear agreement or disagreement with the publication.

InterestModerate interest

There is moderate interest demonstrated by addressing specific health issues like libido loss and depression linked to testosterone levels.

EngagementModerate engagement

Participants analyze symptoms and their correlations, indicating some level of detailed consideration and engagement with the content.

ImpactNeutral impact

The overall discourse does not suggest a significant influence on public health attitudes or policy but indicates awareness of the topic's relevance.

Abstract in brief

  • Low testosterone levels are common in men, especially as they age, but diagnosing hypogonadism is often overlooked and controversial.
  • The decision to treat low testosterone in older men involves weighing potential benefits against risks, and current guidelines vary, making treatment decisions complex.
  • Proper diagnosis, individualized treatment plans, and careful monitoring are essential to maximize benefits and reduce risks in testosterone replacement therapy.]

Top posts

Most liked on X and Bluesky
Urólogo Patricio
@endouropat · X

Testosterona: Pérdida de la libido valor < 12 nmol / L cuando también surge la obesidad. Depresión , la falta de concentración y las alteraciones del sueño < 10 nmol / L y disfunción eréctil < 8 nmol / L. doi:10.1016/j.metabol.2018.03.007

Jul 8, 2020 · 6 likes · 2 shares · 784 followers View post →
Urólogo Patricio
@endouropat · X

https://t.co/1wT12uQCxT

Jul 8, 2020 · 784 followers View post →
Alejandra Cabrera
@AlejandraCabr01 · X

RT @pato_239: Testosterona: Pérdida de la libido valor < 12 nmol / L cuando también surge la obesidad. Depresión , la falta de concentració…

Jul 9, 2020 · 2 shares · 228 followers View post →
Alejandro Madero
@madero22 · X

RT @pato_239: Testosterona: Pérdida de la libido valor < 12 nmol / L cuando también surge la obesidad. Depresión , la falta de concentració…

Jul 9, 2020 · 2 shares · 79 followers View post →

All mentions

Alejandra Cabrera
@AlejandraCabr01 · X

RT @pato_239: Testosterona: Pérdida de la libido valor < 12 nmol / L cuando también surge la obesidad. Depresión , la falta de concentració…

Jul 9, 2020 · 2 shares · 228 followers View post →
Alejandro Madero
@madero22 · X

RT @pato_239: Testosterona: Pérdida de la libido valor < 12 nmol / L cuando también surge la obesidad. Depresión , la falta de concentració…

Jul 9, 2020 · 2 shares · 79 followers View post →
Urólogo Patricio
@endouropat · X

https://t.co/1wT12uQCxT

Jul 8, 2020 · 784 followers View post →
Urólogo Patricio
@endouropat · X

Testosterona: Pérdida de la libido valor < 12 nmol / L cuando también surge la obesidad. Depresión , la falta de concentración y las alteraciones del sueño < 10 nmol / L y disfunción eréctil < 8 nmol / L. doi:10.1016/j.metabol.2018.03.007

Jul 8, 2020 · 6 likes · 2 shares · 784 followers View post →